Ginkgo Bioworks Holdings Inc
NYSE:DNA
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Price:
6.67
USD
-2.34%
Market Cap:
$393m
Balance Sheet
Balance Sheet Decomposition
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
Balance Sheet Decomposition is not available for
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
Balance Sheet
Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
495
|
381
|
1 550
|
1 316
|
944
|
562
|
167
|
|
| Cash Equivalents |
495
|
381
|
1 550
|
1 316
|
944
|
562
|
167
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
255
|
|
| Total Receivables |
9
|
24
|
150
|
84
|
32
|
22
|
24
|
|
| Accounts Receivables |
8
|
22
|
136
|
83
|
18
|
22
|
24
|
|
| Other Receivables |
1
|
2
|
14
|
2
|
14
|
0
|
0
|
|
| Inventory |
0
|
3
|
3
|
4
|
0
|
0
|
0
|
|
| Other Current Assets |
8
|
19
|
20
|
46
|
26
|
19
|
25
|
|
| Total Current Assets |
512
|
427
|
1 723
|
1 450
|
1 002
|
603
|
472
|
|
| PP&E Net |
63
|
121
|
146
|
716
|
397
|
598
|
529
|
|
| PP&E Gross |
63
|
121
|
146
|
716
|
397
|
598
|
529
|
|
| Accumulated Depreciation |
22
|
34
|
61
|
93
|
121
|
161
|
191
|
|
| Intangible Assets |
4
|
3
|
22
|
111
|
83
|
73
|
57
|
|
| Goodwill |
2
|
2
|
21
|
60
|
49
|
0
|
0
|
|
| Note Receivable |
4
|
13
|
0
|
0
|
14
|
14
|
0
|
|
| Long-Term Investments |
107
|
103
|
115
|
114
|
79
|
49
|
15
|
|
| Other Long-Term Assets |
6
|
6
|
44
|
89
|
42
|
41
|
47
|
|
| Other Assets |
2
|
2
|
21
|
60
|
49
|
0
|
0
|
|
| Total Assets |
697
N/A
|
675
-3%
|
2 071
+207%
|
2 539
+23%
|
1 665
-34%
|
1 377
-17%
|
1 120
-19%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
14
|
8
|
11
|
9
|
14
|
11
|
|
| Accrued Liabilities |
14
|
28
|
93
|
115
|
72
|
46
|
53
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Liabilities |
23
|
31
|
33
|
48
|
81
|
47
|
32
|
|
| Total Current Liabilities |
40
|
73
|
135
|
173
|
164
|
107
|
96
|
|
| Long-Term Debt |
17
|
17
|
22
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
9
|
9
|
62
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
139
|
115
|
347
|
630
|
404
|
554
|
515
|
|
| Total Liabilities |
204
N/A
|
214
+5%
|
566
+165%
|
803
+42%
|
568
-29%
|
661
+16%
|
611
-8%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
341
|
468
|
2 298
|
4 398
|
5 291
|
5 838
|
6 150
|
|
| Additional Paid In Capital |
834
|
929
|
3 805
|
6 136
|
6 386
|
6 555
|
6 657
|
|
| Other Equity |
0
|
0
|
2
|
3
|
1
|
2
|
2
|
|
| Total Equity |
493
N/A
|
461
-6%
|
1 505
+226%
|
1 736
+15%
|
1 097
-37%
|
716
-35%
|
509
-29%
|
|
| Total Liabilities & Equity |
697
N/A
|
675
-3%
|
2 071
+207%
|
2 539
+23%
|
1 665
-34%
|
1 377
-17%
|
1 120
-19%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
1 875
|
1 875
|
1 611
|
1 892
|
50
|
54
|
58
|
|
Switch to:
Switch to:
See Also
Discover More
